Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01257321
Other study ID # OSA-HMO-CTIL
Secondary ID
Status Not yet recruiting
Phase N/A
First received December 8, 2010
Last updated December 8, 2010

Study information

Verified date December 2010
Source Hadassah Medical Organization
Contact Nir Hirshoren, MD
Phone 0097226776476
Email drnir@hadassah.org.il
Is FDA regulated No
Health authority Israel: Ministry of Health - Director General
Study type Observational

Clinical Trial Summary

Obstructive sleep apnea syndrome (OSAS) is the most common indication for tonsillectomy and adenoidectomy in young children. According to previous studies, as much as 8 to 20% of patients will develop post operative respiratory complications requiring medical intervention. The pre-operative risk factors that could predict respiratory complications retrospectively analyzed were young age, obesity and high preoperative apnea-hypopnea index. Despite the removal of obstructing lymphoid tissue, upper airway obstruction occurs on the first postoperative night in children with OSA. There is a debate regarding the post-operative duration and monitoring needed in children with OSA.

Hypothesis:

Pre-operative, operative and immediate post-operative parameters could predict post tonsillectomy respiratory complications.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date
Est. primary completion date
Accepts healthy volunteers
Gender Both
Age group N/A to 14 Years
Eligibility Inclusion Criteria:

1. Pediatric patient < 14 years old

2. Obstructive sleep apnea according to polysomnography

3. Surgery: Tonsillectomy/Tonsillotomy

Exclusion Criteria:

1. Patient suffering from known respiratory disease

Study Design

Observational Model: Case-Crossover, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Post Tonsillectomy Respiratory Complications

Locations

Country Name City State
Israel Hadassah Medical Organization Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary respiratory distress